{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:58:55Z","timestamp":1774083535276,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009481","name":"Tata Sons","doi-asserted-by":"publisher","award":["BT\/HRD\/35\/01\/03\/2013"],"award-info":[{"award-number":["BT\/HRD\/35\/01\/03\/2013"]}],"id":[{"id":"10.13039\/501100009481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nbd.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:17:33Z","timestamp":1496236653000},"page":"99-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome"],"prefix":"10.1016","volume":"105","author":[{"given":"Imran","family":"Jamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naman","family":"Vatsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-407X","authenticated-orcid":false,"given":"Shashi","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-4211","authenticated-orcid":false,"given":"Nihar Ranjan","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.05.010_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng0997-75","article-title":"Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons","volume":"17","author":"Albrecht","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0010","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pharep.2015.04.004","article-title":"Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia","volume":"67","author":"Bator","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.nbd.2017.05.010_bb0015","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2017.05.010_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2017.05.010_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.nbd.2017.05.010_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/8.1.129","article-title":"The spectrum of mutations in UBE3A causing Angelman syndrome","volume":"8","author":"Fang","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0035","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.010_bb0040","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/hmg\/ddr614","article-title":"Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome","volume":"21","author":"Godavarthi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0045","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2017.05.010_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/physrev.00012.2010","article-title":"Epigenetic regulation of gene expression in physiological and pathological brain processes","volume":"91","author":"Graff","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2017.05.010_bb0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Graff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.05.010_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2010.01.026","article-title":"The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc","volume":"140","author":"Greer","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.05.010_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.05.010_bb0070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2165\/00148581-200305100-00001","article-title":"Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms","volume":"5","author":"Guerrini","year":"2003","journal-title":"Paediatr. Drugs."},{"key":"10.1016\/j.nbd.2017.05.010_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0080","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/hmg\/ddn117","article-title":"Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors","volume":"17","author":"Heck","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0085","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.010_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.05.010_bb0095","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1073\/pnas.92.11.5249-a","article-title":"A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase","volume":"92","author":"Huibregtse","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.nbd.2017.05.010_bb0100","doi-asserted-by":"crossref","first-page":"710943","DOI":"10.1155\/2012\/710943","article-title":"Understanding the pathogenesis of Angelman syndrome through animal models","volume":"2012","author":"Jana","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2017.05.010_bb0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","article-title":"Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation","volume":"21","author":"Jiang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.010_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4161\/cc.10.3.14712","article-title":"Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis","volume":"10","author":"Jurkin","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nbd.2017.05.010_bb0115","doi-asserted-by":"crossref","DOI":"10.3791\/2473","article-title":"Assessment of social interaction behaviors","author":"Kaidanovich-Beilin","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2017.05.010_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0197-70","article-title":"UBE3A\/E6-AP mutations cause Angelman syndrome","volume":"15","author":"Kishino","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0125","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2017.05.010_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2017.05.010_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","article-title":"Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes","volume":"34","author":"Mabb","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2017.05.010_bb0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0197-74","article-title":"De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome","volume":"15","author":"Matsuura","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","article-title":"Towards a therapy for Angelman syndrome by targeting a long non-coding RNA","volume":"518","author":"Meng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.05.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.010_bb0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.nbd.2010.08.002","article-title":"Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome","volume":"40","author":"Mulherkar","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.010_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","article-title":"Effect of sodium valproate administration on brain neprilysin expression and memory in rats","volume":"46","author":"Nalivaeva","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.010_bb0165","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/scisignal.aaa0069","article-title":"Histone deacetylases in memory and cognition","volume":"7","author":"Penney","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2017.05.010_bb0170","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.06006","article-title":"E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors","volume":"6","author":"Ramamoorthy","year":"2008","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.nbd.2017.05.010_bb0175","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M109.006312","article-title":"Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease","volume":"285","author":"Rao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.05.010_bb0180","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1086\/302917","article-title":"Parent-of-origin specific histone acetylation and reactivation of a key imprinted gene locus in Prader-Willi syndrome","volume":"66","author":"Saitoh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0185","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1073\/pnas.1001281107","article-title":"Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a","volume":"107","author":"Sato","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.010_bb0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cub.2014.12.047","article-title":"Ube3a imprinting impairs circadian robustness in Angelman syndrome models","volume":"25","author":"Shi","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2017.05.010_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.224","article-title":"Toward dissecting the etiology of schizophrenia: HDAC1 and DAXX regulate GAD67 expression in an in vitro hippocampal GABA neuron model","volume":"6","author":"Subburaju","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2017.05.010_bb0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.celrep.2015.06.023","article-title":"UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis","volume":"12","author":"Sun","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2017.05.010_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neuron.2012.03.036","article-title":"Maternal loss of Ube3a produces an excitatory\/inhibitory imbalance through neuron type-specific synaptic defects","volume":"74","author":"Wallace","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.010_bb0210","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1523\/JNEUROSCI.23-07-02634.2003","article-title":"Derangements of hippocampal calcium\/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome","volume":"23","author":"Weeber","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.010_bb0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.a.31074","article-title":"Angelman syndrome 2005: updated consensus for diagnostic criteria","volume":"140","author":"Williams","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.nbd.2017.05.010_bb0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/GIM.0b013e3181def138","article-title":"Clinical and genetic aspects of Angelman syndrome","volume":"12","author":"Williams","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.nbd.2017.05.010_bb0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddg106","article-title":"Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a","volume":"12","author":"Yamasaki","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.010_bb0230","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10571-013-0012-y","article-title":"Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action","volume":"34","author":"Yao","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2017.05.010_bb0235","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nn.2327","article-title":"Ube3a is required for experience-dependent maturation of the neocortex","volume":"12","author":"Yashiro","year":"2009","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:11:56Z","timestamp":1760850716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117301225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":47,"alternative-id":["S0969996117301225"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}